← Back to Search

Hip Capsule Repair for Hip Pain

N/A
Waitlist Available
Led By Aaron J Krych
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
FAI documented on X-Ray or Magnetic resonance imaging (MRI) or magnetic resonance arthrogram (MRA)
Intraoperative labral repair or intact labrum
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months
Awards & highlights

Study Summary

This trial is testing whether or not repairing the hip joint capsule (a ligament) will improve function and quality of life for people with hip pain.

Who is the study for?
The CREST trial is for adults aged 18 to 50 with hip pain lasting over three months that hasn't improved with non-surgical treatments. Participants must have FAI confirmed by imaging, an intact labrum or one repaired during surgery, and be able to understand and speak English.Check my eligibility
What is being tested?
This study tests if repairing the hip capsule during arthroscopy improves function. It involves 240 patients split into two groups, comparing outcomes like hip motion and satisfaction at six months post-surgery using a blinded approach.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks of hip arthroscopy may include discomfort at the incision site, temporary numbness or tingling due to anesthesia, joint stiffness, bruising around the hip area, and less commonly infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hip issue is confirmed by an X-Ray, MRI, or MRA.
Select...
I have had surgery to fix or have an intact shoulder labrum.
Select...
I am between 18 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hip Function
Secondary outcome measures
Hip ROM
Visual Analog Pain Score Progression

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hip Capsule RepairExperimental Treatment1 Intervention
Patients in the intervention group (Hip capsule repair) will undergo initial diagnostic arthroscopy of the hip. Two to three standard portals (anterolateral, mid anterior, distal antero-lateral, posterolateral) will be used during the entire procedure to assess and treat the patient. After establishing standard portals, an interportal capsulotomy is completed to allow for complete evaluation of the central compartment of the hip. In the central compartment, significant and obvious pathologies will be addressed accordingly. Following addressing central compartment pathologies, cam impingement type lesions in the peripheral compartment will be treated. Once all pathologies are addressed, the interportal capsulotomy10 will be repaired by using simple interrupted sutures with absorbable suture (Number 1 Vicryl). Three to four simples sutures will be placed and tied using arthroscopic technique.
Group II: No Hip Capsule Repair (Control)Active Control1 Intervention
Patients in the control group (no hip capsule repair) have the same portals utilized and will have the same interportal capsulotomy performed. They will have all central and peripheral compartment pathologies addressed in the same way that the study group does. At the conclusion of the case, the hip capsule will be left open and not repaired.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,766,800 Total Patients Enrolled
1 Trials studying Hip Arthroscopy
188 Patients Enrolled for Hip Arthroscopy
Aaron J KrychPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
49 Total Patients Enrolled

Media Library

Hip Capsule Repair Clinical Trial Eligibility Overview. Trial Name: NCT03372564 — N/A
Hip Arthroscopy Research Study Groups: Hip Capsule Repair, No Hip Capsule Repair (Control)
Hip Arthroscopy Clinical Trial 2023: Hip Capsule Repair Highlights & Side Effects. Trial Name: NCT03372564 — N/A
Hip Capsule Repair 2023 Treatment Timeline for Medical Study. Trial Name: NCT03372564 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age range for this research trial limited to individuals aged 35 and under?

"According to the prerequisites for this clinical trial, individuals between 18 and 50 years old are eligible."

Answered by AI

How can I participate in this medical research?

"Requisites for acceptance into this medical trial include arthroscopy and an age range between 18 to 50 years old. The research is aiming to recruit a cohort of 240 volunteers."

Answered by AI

How many individuals have been enrolled in this clinical trial thus far?

"This medical trial necessitates 240 eligible participants from multiple sites including Mayo Clinic in Arizona, Scottsdale and the Rochester branch of Mayo Clinic."

Answered by AI

Are patients currently being enrolled in this trial?

"Affirmative. As per information listed on clinicaltrials.gov, the medical trial is actively recruiting for 240 participants at 3 sites. It was initially posted November 7th 2017 and last updated December 23rd 2021."

Answered by AI
Recent research and studies
~167 spots leftby Dec 2040